Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome

by Jahanzaib Khwaja, Ryan Keh, Duncan Smyth, Michael Peter Lunn, Shirley D'Sa, Jonathan Sive
Published 2022-08-01

Understanding patterns of fatigue in health and disease: protocol for an ecological momentary assessment study using digital technologies

by Katherine Bradbury, Rosalind Adam, Daniel Powell, Stephen Green, Jonathan Sive, Yojana Lotankar, Corina Sas, Veronica Martinez, Jonathan Cooper, Derek L Hill
Published 2024-05-01

Comprehensive Diagnosis and Management of POEMS Syndrome

by Shirley D’Sa, Jahanzaib Khwaja, Stephen Keddie, Ryan YS Keh, Duncan Smyth, Ruth Ronneberger, Suraiya Dubash, Suganya Sivabalasingham, Simon Wan, Chandrashekar Hoskote, Stephanie Baldeweg, Jonathan Sive, Michael P. Lunn
Published 2022-11-01

PB2108: SPINAL INVOLVEMENT IS ASSOCIATED WITH HIGH INCIDENCE OF SKELETAL RELATED EVENTS AND INFERIOR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA. A SINGLE CENTRE EXPERIENCE...

by Nikolaos Kanellias, Agapi Parcharidou, Ke Xu, Rodothea Americanou, Adam Benton, Sean Molloy, Jan Herzog, Rigin Hargunani, Kwee Yong, Rakesh Popat, Jonathan Sive, Lydia Lee, Annabel Mcmilan, Xenofon Papanikolaou, Neil Rabin, Charalampia Kyriakou
Published 2023-08-01

Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma

by Samir Asher, Aikaterini Kazantzi, Fatjon Dekaj, Luke Steventon, Aisha Khatun, Louise Ainley, Annabel McMillan, Neil Rabin, Ashu Wechalekar, Jonathan Sive, Charalampia Kyriakou, Xenofon Papanikolaou, Ke Xu, Shameem Mahmood, Brendan Wisniowski, Lydia Lee, Kwee Yong, Rakesh Popat
Published 2022-08-01

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION

by Amrutha Sridhar, Selina Chavda, Hannah Hsu, Hanna Renshaw, Tatianna Fernandes, Catriona Maciter, Samir Asher, Neil Rabin, Jonathan Sive, Charalampia Kyriakou, Xenofon Papanikolaou, Ke Xu, Ashutosh Wechalekar, Shameem Mahmood, Annabel Mcmillan, Lydia Lee, Kwee Yong, Fatjon Dekaj, Rakesh Popat
Published 2023-08-01

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma

by Catherine S. Y. Lecat, Catherine S. Y. Lecat, Jessica B. Taube, William Wilson, Jonathan Carmichael, Jonathan Carmichael, Christopher Parrish, Gabriel Wallis, Charalampia Kyriakou, Lydia Lee, Shameem Mahmood, Xenofon Papanikolaou, Neil K. Rabin, Jonathan Sive, Ashutosh D. Wechalekar, Kwee Yong, Gordon Cook, Gordon Cook, Rakesh Popat
Published 2021-07-01

High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis

by Jahanzaib Khwaja, Joshua Bomsztyk, Shameem Mahmood, Brendan Wisniowski, Raakhee Shah, Anish Tailor, Kwee Yong, Rakesh Popat, Neil Rabin, Charalampia Kyriakou, Jonathan Sive, Simona Degli Esposti, Daniel F. P. Larkin, Sarah Worthington, Alyse Hart, Emma Dowling, Nuno Correia, Ceri Bygrave, Andrzej Rydzewski, Krzysztof Jamroziak, Ashutosh D. Wechalekar
Published 2022-09-01

Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a...

by Roger Owen, Mark Cook, David Meads, David A Cairns, Christopher Parrish, Gordon Cook, Kwee Yong, Guy Pratt, Martin Kaiser, Karthik Ramasamy, Graham Jackson, Catherine Olivier, Amy Beth Coulson, Kara-Louise Royle, Anna Hockaday, Ruth de Tute, Bryony Dawkins, Mark Drayson, Jonathan Sive, Holger W Auner, Sergio Quezada, Lorna Barnard, Rhiannon Lambkin, Andrea Paterson, Mike Chapman, Rakesh Popat, Ceri Bygrave, Andrew Chantry, Samir Asher
Published 2022-11-01